Smad linker region phosphorylation in the regulation of extracellular matrix synthesis.
The canonical TGF-β signalling pathway involves Smad transcription factors through direct serine phosphorylation of the carboxy termini, nuclear translocation and regulation of transcription by receptor-regulated (R)-Smad complexes. Smads can also be phosphorylated in the linker region most prominently by the action of mitogen-activated protein (MAP) kinases, which in turn have been activated by TGF-β or a multitude of other growth factors and hormones. Linker region phosphorylation can prevent nuclear translocation of Smads and inhibit TGF-β signalling, potentially leading to oncogenesis. However, some evidence has revealed that linker region phosphorylated Smads can be translocated to the nucleus where they regulate transcription particularly of the synthesis of extracellular matrix molecules. Matrix molecules such as collagen and proteoglycans are involved in diseases such a fibrosis and atherosclerosis, respectively, and the involvement of linker region phosphorylation may represent a new therapeutic target.
Burch
Micah L
ML
Diabetes and Cell Biology Laboratory, BakerIDI Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC 3004, Australia. micah.burch@bakeridi.edu.au
Zheng
Wenhua
W
Little
Peter J
PJ
D000818:Animals; D003094:Collagen / Q000096:biosynthesis; D005109:Extracellular Matrix / Q000378:metabolism*; D006801:Humans; D020935:MAP Kinase Signaling System; D051379:Mice; D008954:Models, Biological; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000378:metabolism / Q000502:physiology; D011509:Proteoglycans / Q000096:biosynthesis; D051381:Rats; D000077293:Receptor, Transforming Growth Factor-beta Type I; D018125:Receptors, Transforming Growth Factor beta / Q000378:metabolism / Q000502:physiology; D051785:Smad Proteins / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D016212:Transforming Growth Factor beta / Q000235:genetics / Q000378:metabolism / Q000502:physiology
D011509:Proteoglycans; D018125:Receptors, Transforming Growth Factor beta; D051785:Smad Proteins; D016212:Transforming Growth Factor beta; D003094:Collagen; D017346:Protein Serine-Threonine Kinases; D000077293:Receptor, Transforming Growth Factor-beta Type I; C000625843:Tgfbr1 protein, rat
Open Biochem J. 2008;2:135-42
19238187
Genes Dev. 2003 Dec 15;17(24):2993-7
14701870
Arterioscler Thromb Vasc Biol. 2002 Jan;22(1):55-60
11788461
J Biol Chem. 2001 Apr 27;276(17):14466-73
11278290
J Biol Chem. 2006 Dec 29;281(52):39870-80
17074756
Circulation. 2007 Oct 16;116(16):1832-44
17938300
Genes Dev. 2000 Oct 15;14(20):2610-22
11040215
Cell Signal. 2002 Sep;14(9):733-43
12034354
Am J Pathol. 2005 Apr;166(4):1029-39
15793284
Nature. 2003 Oct 9;425(6958):577-84
14534577
J Cell Mol Med. 2010 Jun;14(6B):1408-18
19754668
Am J Pathol. 2002 Dec;161(6):2111-21
12466127
Nat Rev Mol Cell Biol. 2007 Nov;8(11):857-69
17895899
J Allergy Clin Immunol. 2009 Aug;124(2):253-9, 259.e1-2
19500825
Genes Dev. 1999 Apr 1;13(7):804-16
10197981
Genes Dev. 2005 Dec 1;19(23):2783-810
16322555
EMBO J. 2007 Sep 5;26(17):3957-67
17673906
Cell Growth Differ. 1997 Jul;8(7):821-7
9218876
Curr Vasc Pharmacol. 2005 Jan;3(1):55-61
15638782
Cell Mol Life Sci. 2004 Jun;61(11):1296-306
15170508
FASEB J. 2003 Aug;17(11):1576-8
12824291
Cell. 1996 May 17;85(4):489-500
8653785
Arterioscler Thromb Vasc Biol. 1995 May;15(5):551-61
7749869
Clin Sci (Lond). 2008 Oct;115(7):203-18
18752467
Atherosclerosis. 2002 May;162(1):119-29
11947905
Mol Cell. 2009 Nov 13;36(3):457-68
19917253
J Biol Chem. 2008 Mar 21;283(12):7844-52
18223258
Cardiovasc Res. 2008 Jul 1;79(1):14-23
18430750
J Biol Chem. 1987 Apr 15;262(11):5065-72
3031038
Biochem Biophys Res Commun. 2009 May 1;382(2):259-63
19285964
Nature. 2001 May 17;411(6835):355-65
11357143
Development. 2009 Nov;136(22):3691-7
19855012
Development. 2009 Nov;136(22):3699-714
19855013
Curr Opin Lipidol. 2008 Oct;19(5):448-54
18769225
Biochim Biophys Acta. 2008 Apr;1782(4):197-228
18313409
Thromb Res. 2008;123(2):288-97
18571697
Cell Res. 2009 Jan;19(1):89-102
19050696
Mol Cell Biol. 2000 Nov;20(21):8103-11
11027280
Arch Pharm Res. 2007 Jun;30(6):739-42
17679552
J Lipid Res. 2002 Jan;43(1):149-57
11792734
Vasc Health Risk Manag. 2007;3(1):117-24
17583182
Dev Dyn. 2009 Jul;238(7):1688-700
19517569
Biochem Biophys Res Commun. 1992 Mar 16;183(2):694-700
1550575
Atherosclerosis. 2009 Aug;205(2):451-7
19217622
Cell Mol Life Sci. 2010 Jun;67(12):2077-90
20213272
Nature. 1996 Feb 8;379(6565):557-60
8596637
Biochem Biophys Res Commun. 2009 Aug 21;386(2):289-93
19465000
J Biol Chem. 1997 Jan 31;272(5):2896-900
9006934
Expert Opin Pharmacother. 2009 Jul;10(10):1587-603
19527187
Carcinogenesis. 2008 Feb;29(2):244-51
18174260
Arthritis Rheum. 2009 Jul;60(7):2142-55
19565505
Genes Cells. 2009 Jan;14(1):17-28
19032343
Atherosclerosis. 2008 Aug;199(2):237-47
18436225
Nature. 1997 Dec 4;390(6659):465-71
9393997
FASEB J. 2008 Jun;22(6):1769-77
18218921
Oncogene. 2007 May 14;26(22):3100-12
17496909
Science. 1995 Dec 22;270(5244):2008-11
8533096
Cancer Res. 2008 Nov 15;68(22):9107-11
19010878
J Biol Chem. 2009 Apr 10;284(15):9663-73
19218245
J Clin Invest. 1993 Dec;92(6):3003-7
8254054
Expert Rev Gastroenterol Hepatol. 2009 Feb;3(1):1-3
19210106
Biochem J. 2005 Feb 15;386(Pt 1):e1-e3
15702493
J Biol Chem. 2003 Mar 28;278(13):11041-9
12538652
Am J Physiol. 1990 Mar;258(3 Pt 1):C408-15
1690514
Cell. 2009 Nov 13;139(4):757-69
19914168
Am J Pathol. 1998 Feb;152(2):533-46
9466580
Annu Rev Biochem. 1998;67:753-91
9759503
Nature. 1997 Oct 9;389(6651):618-22
9335504
Arch Physiol Biochem. 2009 Jul;115(3):147-54
19580379
J Mol Cell Cardiol. 2001 Jan;33(1):3-7
11133218
Cell. 2000 Oct 13;103(2):295-309
11057902
Zhonghua Yi Xue Za Zhi. 2004 Apr 2;84(7):574-7
15144593